JMP Securities Maintains Market Outperform on Dynavax Technologies, Raises Price Target to $27
Portfolio Pulse from Benzinga Newsdesk
JMP Securities analyst Roy Buchanan maintains a Market Outperform rating on Dynavax Technologies (NASDAQ:DVAX) and raises the price target from $25 to $27.

November 03, 2023 | 7:43 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Dynavax Technologies' price target has been raised from $25 to $27 by JMP Securities, maintaining a Market Outperform rating.
The news of JMP Securities raising the price target for Dynavax Technologies from $25 to $27 while maintaining a Market Outperform rating is likely to have a positive impact on the company's stock in the short term. This is because such an upgrade usually signals the analyst's increased confidence in the company's future performance, which can encourage investors to buy the stock, potentially driving up its price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100